IV Nerve Support
Type
IV Vitamin Therapy
Duration
45 min
An intravenous infusion featuring alpha-lipoic acid and supporting antioxidants, formulated for individuals with inflammatory concerns. Alpha-lipoic acid is a potent antioxidant that is both water-soluble and fat-soluble, allowing it to work across cell membranes and support nerve tissue integrity.
The Nerve Support IV centres on alpha-lipoic acid (ALA), a unique antioxidant that functions in both aqueous and lipid environments — unlike most antioxidants, which are limited to one or the other. This dual solubility allows ALA to cross cell membranes and provide antioxidant protection in neural tissue, where oxidative stress can damage myelin sheaths and impair nerve signalling. ALA also regenerates other antioxidants, including vitamins C and E and glutathione, effectively extending their functional lifespan. It chelates certain heavy metals and modulates inflammatory pathways through NF-kB signalling. Research has examined ALA supplementation in the context of peripheral neuropathy, with some studies suggesting improvements in nerve conduction velocity and symptom scores. Intravenous delivery achieves plasma concentrations that oral supplementation cannot match, as oral ALA has relatively low and variable bioavailability (approximately 20-30%). The infusion takes approximately 40 to 50 minutes and is administered by a registered nurse. This drip is suitable for individuals interested in antioxidant support, those with inflammatory concerns, or anyone whose healthcare provider has recommended alpha-lipoic acid as part of their care plan.
Key Details
- Focus
- Nerve support and anti-inflammatory
- Key nutrient
- Alpha-lipoic acid (dual-soluble antioxidant)
- Duration
- 40-50 minutes
Who Is This For?
Individuals with inflammatory concerns, those interested in neuroprotective antioxidant support, and anyone whose healthcare provider has recommended alpha-lipoic acid
What's Included
Preparation Required
Eat a light meal beforehand. Bring any relevant medical reports if this is part of a treatment plan. Initial consultation required.

